Drugs for inflammatory and fibrotic diseases
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
258
NCT06762457
A First-in-Human Single and Multiple Ascending Dose Study of MT-501
Phase: Phase 1
Role: Lead Sponsor
Start: Dec 11, 2024
Completion: Jan 31, 2026
NCT07113522
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Phase: Phase 2
Start: Jun 26, 2025
Completion: May 7, 2027
NCT07219368
A First-in-Human Single and Multiple Ascending Dose Study of MT-201
Start: Oct 8, 2025
Completion: Dec 31, 2026
Loading map...